| Structural basis for gluten intolerance in celiac sprue L Shan, Ø Molberg, I Parrot, F Hausch, F Filiz, GM Gray, LM Sollid, ... Science 297 (5590), 2275-2279, 2002 | 2057 | 2002 |
| Intestinal digestive resistance of immunodominant gliadin peptides F Hausch, L Shan, NA Santiago, GM Gray, C Khosla American Journal of Physiology-Gastrointestinal and Liver Physiology 283 (4 …, 2002 | 502 | 2002 |
| FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior C Touma, NC Gassen, L Herrmann, J Cheung-Flynn, DR Büll, IA Ionescu, ... Biological psychiatry 70 (10), 928-936, 2011 | 291 | 2011 |
| The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress J Hartmann, KV Wagner, C Liebl, SH Scharf, XD Wang, M Wolf, F Hausch, ... Neuropharmacology 62 (1), 332-339, 2012 | 255 | 2012 |
| Selective inhibitors of the FK506-binding protein 51 by induced fit S Gaali, A Kirschner, S Cuboni, J Hartmann, C Kozany, G Balsevich, ... Nature chemical biology 11 (1), 33-37, 2015 | 247 | 2015 |
| Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-κB–driven inflammation and cardiovascular risk AS Zannas, M Jia, K Hafner, J Baumert, T Wiechmann, JC Pape, J Arloth, ... Proceedings of the National Academy of Sciences 116 (23), 11370-11379, 2019 | 225 | 2019 |
| FKBP ligands—where we are and where to go? JM Kolos, AM Voll, M Bauder, F Hausch Frontiers in pharmacology 9, 427516, 2018 | 140 | 2018 |
| Large FK506-binding proteins shape the pharmacology of rapamycin AM März, AK Fabian, C Kozany, A Bracher, F Hausch Molecular and cellular biology, 2013 | 123 | 2013 |
| Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function G Balsevich, AS Häusl, CW Meyer, S Karamihalev, X Feng, ML Pöhlmann, ... Nature communications 8 (1), 1725, 2017 | 118 | 2017 |
| A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease M Riebold, C Kozany, L Freiburger, M Sattler, M Buchfelder, F Hausch, ... Nature Medicine 21 (3), 276-280, 2015 | 118 | 2015 |
| Pharmacological inhibition of the psychiatric risk factor FKBP51 has anxiolytic properties J Hartmann, KV Wagner, S Gaali, A Kirschner, C Kozany, G Rühter, ... Journal of Neuroscience 35 (24), 9007-9016, 2015 | 114 | 2015 |
| The prospect of FKBP51 as a drug target MV Schmidt, M Paez‐Pereda, F Holsboer, F Hausch ChemMedChem 7 (8), 1351-1359, 2012 | 114 | 2012 |
| Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase F Hausch, T Halttunen, M Mäki, C Khosla Chemistry & Biology 10 (3), 225-231, 2003 | 107 | 2003 |
| Fluorescent probes to characterise FK506‐binding proteins C Kozany, A März, C Kress, F Hausch ChemBioChem 10 (8), 1402-1410, 2009 | 105 | 2009 |
| The many faces of FKBP51 A Hähle, S Merz, C Meyners, F Hausch Biomolecules 9 (1), 35, 2019 | 99 | 2019 |
| The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling M Maiarù, KK Tochiki, MB Cox, LV Annan, CG Bell, X Feng, F Hausch, ... Science translational medicine 8 (325), 325ra19-325ra19, 2016 | 99 | 2016 |
| A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma P D’Arrigo, M Russo, A Rea, M Tufano, E Guadagno, MLDB De Caro, ... Oncotarget 8 (40), 68291, 2017 | 86 | 2017 |
| FKBPs and the Akt/mTOR pathway F Hausch, C Kozany, M Theodoropoulou, AK Fabian Cell Cycle 12 (15), 2366-2370, 2013 | 85 | 2013 |
| FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma S Romano, Y Xiao, M Nakaya, A D'Angelillo, M Chang, J Jin, F Hausch, ... Nucleic acids research 43 (14), 6983-6993, 2015 | 81 | 2015 |
| Orexin–corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine G Navarro, C Quiroz, D Moreno-Delgado, A Sierakowiak, K McDowell, ... Journal of Neuroscience 35 (17), 6639-6653, 2015 | 79 | 2015 |
